EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema

Irmgard Andresen, Natalie Khutoryansky, Sarah L Feeny, Alissa Dangel

Drugs in R&D · 2026-03 · 26 (1) · 31-33

DOI: 10.1007/s40268-026-00539-8 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Drugs in R&D, online erschienen am 28.03.2026. Verfasst von Irmgard Andresen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Pharmaceuticals International AG, Thurgauerstrasse 130, CH-8152 Glattpark-Opfikon, Zurich, Switzerland. irmgard.andresen@takeda.com. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Development Center Americas, Inc.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We read with interest the recent publication

Autor:innen und Institutionen

  • Takeda Pharmaceuticals International AG, Thurgauerstrasse 130, CH-8152 Glattpark-Opfikon, Zurich, Switzerland. irmgard.andresen@takeda.com.
  • Takeda Development Center Americas, Inc., Lexington, MA, USA.
  • Takeda Pharmaceuticals USA, Inc., Cambridge, MA, USA.

Förderung

  • Takeda Development Center Americas, Inc

Zitieren

APA

Andresen, I., Khutoryansky, N., Feeny, S. L., & Dangel, A. (2026). Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema. Drugs in R&D, 26(1), 31-33. https://doi.org/10.1007/s40268-026-00539-8

Vancouver

Andresen I, Khutoryansky N, Feeny SL, Dangel A. Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema. Drugs in R&D. 2026;26(1):31-33. doi:10.1007/s40268-026-00539-8

BibTeX
@article{Andresen2026,
  author = {Andresen, Irmgard and Khutoryansky, Natalie and Feeny, Sarah L and Dangel, Alissa},
  title = {Treatment Outcomes with Lanadelumab Every 2 Weeks and Garadacimab are Very Similar in Patients with Hereditary Angioedema},
  journal = {Drugs in R&D},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {31--33},
  doi = {10.1007/s40268-026-00539-8}
}
Kostenlos starten →